Chou C, Veracruz N, Chitnis AS, Wong RJ. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis. J Viral Hepat 2022;29:1107-14. [PMID: 36138556 DOI: 10.1111/jvh.13751][Reference Citation Analysis]
2
Zhang T, Li R, Wang L, Tang F, Li H. Clinical relevance of vitamin B12 level and vitamin B12 metabolic gene variation in pulmonary tuberculosis. Front Immunol 2022;13:947897. [DOI: 10.3389/fimmu.2022.947897][Reference Citation Analysis]
3
Wong RJ, Kaufman HW, Niles JK, Meyer WA 3rd, Chitnis AS. Prevalence of Hepatitis B Virus and Latent Tuberculosis Coinfection in the United States. J Public Health Manag Pract 2022;28:452-62. [PMID: 35867500 DOI: 10.1097/PHH.0000000000001536][Reference Citation Analysis]
4
Cooper R, Houston S, Hughes C, Johnston JC. Chapter 10: Treatment of active tuberculosis in special populations. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:149-166. [DOI: 10.1080/24745332.2022.2039500][Reference Citation Analysis]